SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sangamo Therapeutics, Inc. SGMO
An SI Board Since April 2000
Posts SubjectMarks Bans Symbol
368 43 0 SGMO
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
318i like sgmo long term but i sold some on the run up today. expect to buy it backbob zagorin-4/14/2010
317<< Posters at Investors Village speculate that he is pointing to SGMO.>tnsaf-4/14/2010
316What the heck, it's news. And since it may explain today's movement, it&tom pope-4/14/2010
315mistakebob zagorin-4/14/2010
314Newsletterist, Marc Lichtenfeld, touting a micro-cap biotech that he predicts, cD.Lu-4/14/2010
313Q transcript: seekingalpha.combob zagorin-2/5/2010
312Sangamo BioSciences, Inc. (1) MARKET OUTPERFORM Target Price $15.00 INVESTMbob zagorin-2/4/2010
311New hopes over elimination of AIDS * 18 February 2009 [NewScientist] AFTERsim1-1/30/2010
310RICHMOND, Calif., Jan. 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nnigel bates-1/19/2010
309Per Edward Lanphier's comments yesterday, it appears we will get a much awaiPLegee-1/14/2010
308Sangamo BioSciences Advances ZFP Therapeutic(TM) Pipeline Initiation of Two Newsim1-1/11/2010
307RICHMOND, Calif., Dec. 9 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nanigel bates-12/9/2009
306From the IV board... Gene surgery Cath O’Driscoll, 23/11/2009 New tools for sim1-11/25/2009
305RICHMOND, Calif. Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nanigel bates-10/28/2009
304Sangamo BioSciences Announces Presentation of Top-Line Statistically Significantsim1-10/21/2009
303Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technolnigel bates-10/5/2009
302Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Celnigel bates-10/1/2009
301RICHMOND, Calif., Sept. 23 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (nigel bates-9/23/2009
300Sangamo's Zinc Finger Nuclease Technology Used to Efficiently Modify Human Ssim119/8/2009
299Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technenzyme-7/23/2009
298businesswire OMT Announces a Breakthrough in the Development of a Novel Human Anenzyme-7/23/2009
297RICHMOND, Calif., June 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nnigel bates-6/29/2009
296Notable Calls with color on Merriman's buy reiteration & doubling of prituck-6/22/2009
295Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 sim1-6/8/2009
294Phase 2 interm results. SB509 turns DN blocked nerves back on! Here's the tenzyme-5/18/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News